PMC9726241_01
(a) Extensive papillomas along the epiglottis, bilateral aryepiglottic folds, and bilateral true and false cords with extension into the subglottis (left) and residual small papillomas on the laryngeal surface of the epiglottis after 2 months and 3 treatments of bevacizumab (right). (b) Severe laryngeal papillomas of the left larynx (left) and disappearance of disease after 3 months and 4 treatments of bevacizumab (right). There is a small scar band in the posterior glottis (black arrow).
CRIONM2022-2767996.001.jpg
PMC9726241_02_CRIONM2022-2767996.001.jpg
fig1
Pretreatment direct laryngoscopy showed extensive papillomas along the left true cord, ventricle, and false cord extending to the laryngeal surface of the epiglottis (Figure 1(b)). Direct laryngoscopy after the fourth treatment showed no papillomas and a scar band in the posterior glottis (Figure 1(b)).
PMC9726241_02
(a) Extensive papillomas along the epiglottis, bilateral aryepiglottic folds, and bilateral true and false cords with extension into the subglottis (left) and residual small papillomas on the laryngeal surface of the epiglottis after 2 months and 3 treatments of bevacizumab (right). (b) Severe laryngeal papillomas of the left larynx (left) and disappearance of disease after 3 months and 4 treatments of bevacizumab (right). There is a small scar band in the posterior glottis (black arrow).
CRIONM2022-2767996.001.jpg
PMC9726241_02_CRIONM2022-2767996.001.jpg
fig1
Pretreatment direct laryngoscopy showed extensive papillomas along the left true cord, ventricle, and false cord extending to the laryngeal surface of the epiglottis (Figure 1(b)). Direct laryngoscopy after the fourth treatment showed no papillomas and a scar band in the posterior glottis (Figure 1(b)).